SCHEMBL4969264

SCHEMBL4969264

CC(C)c1c(Cl)c(F)cc2c(=O)c(C(=O)O)c[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 4/20 0.50
CSNK2B P67870 4/20 0.50
CSNK2A1 P68400 4/20 0.50
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
CYP1A2 P05177 2/20 0.40
HSD17B10 Q99714 2/20 0.40
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.38
ALOX12 P18054 1/20 0.38
KMT2A Q03164 1/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38
DNA2 P51530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17769503 0.83 CYP1A2 (0.56) KDM4EALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL8591424 0.83 CSNK2A2 (0.60) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL17769482 0.81 CSNK2A2 (0.47) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL5194351 0.80 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL4974043 0.80 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL11014833 0.79 CSNK2A2 (0.52) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL3812191 0.79 CSNK2A2 (0.49) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL11015195 0.78 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL9085082 0.77 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1
SCHEMBL13484134 0.77 CSNK2A1 (0.56) CSNK2A2CSNK2BCSNK2A1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221295-A1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF Nirogyone Therapeutics, Inc. (US) 2017-09-27 EP disclosed
WO-2016081464-A1 MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF NIROGYONE THERAPEUTICS, INC. (US) 2016-05-26 WO disclosed
EP-1879903-A1 ETHER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS GlaxoSmithKline istrazivacki centar Zagreb d.o.o. (HR) 2008-01-23 EP disclosed
EP-1756135-A1 ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS GlaxoSmithKline istrazivacki centar Zagreb d.o.o. (HR) 2007-02-28 EP disclosed
WO-2006120541-A1 ETHER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (US) 2006-11-16 WO disclosed
WO-2005108412-A1 ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (US) 2005-11-17 WO disclosed